Cognition Therapeutics files investor presentation on pathogenic oligomers approach

COGNITION THERAPEUTICS INC

Filed investor presentation dated June 2025 under Item 8.01.
Presentation focuses on targeting pathogenic oligomers for neurodegenerative diseases.
No financial, clinical, or operational updates provided in the filing.
Presentation may be used in discussions with investors and analysts.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.